Dexcom (DXCM) cash: $918M
Dexcom held $918M in cash and cash equivalents on Dec 31, 2025, up 51.4% from $606M a year earlier.
From Dexcom's filings with the SEC · Read the filing · DXCM stock page
Dexcom cash by year
#567 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $918M | +51% |
| Dec 31, 2024 | $606M | +7% |
| Dec 31, 2023 | $566M | -12% |
| Dec 31, 2022 | $642M | -39% |
| Dec 31, 2021 | $1.1B | – |
Cash of similar companies
Companies in the same industry as Dexcom, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Resmed | $1.4B | Dec 31, 2025 |
| Dexcom | $918M | Dec 31, 2025 |
| Solventum | $878M | Dec 31, 2025 |
| West Pharmaceutical Services | $791M | Dec 31, 2025 |
| Becton Dickinson | $740M | Dec 31, 2025 |
| Insulet | $716M | Dec 31, 2025 |
| Globus Medical | $526M | Dec 31, 2025 |
Questions and answers
What is Dexcom's cash?
Dexcom held $918M in cash and cash equivalents on Dec 31, 2025, up 51.4% from $606M a year earlier.
Numbers as reported in Dexcom's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology